Literature DB >> 28052484

Characterization of isochlorogenic acid A metabolites in rats using high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

Jing Wang1, Guoxiu Cao1, Hong Wang1, Hui Ye1, Yunxi Zhong1, Guangji Wang1, Haiping Hao1.   

Abstract

Isochlorogenic acid A is widely present in fruits, vegetables and herbal medicines, and is characterized by anti-inflammatory, hepatoprotective and antiviral properties. However, little is known about its metabolic fate and pharmacokinetic properties. This study is thus designed to investigate the metabolic fate of isochlorogenic acid A. An analytical method based on high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (HPLC/Q-TOF MS) was established to characterize the metabolites of isochlorogenic acid A in the plasma, urine and feces of rats. A total of 32 metabolites were identified. The metabolic pathways mainly include hydrolyzation, dehydroxylation, hydrogenation and conjugation with methyl, glucuronic acid, glycine, sulfate, glutathione and cysteine. Moreover, the pharmacokinetic profiles of all the circulating metabolites were investigated. M11 resulting from hydrolyzation, dehydroxylation and hydrogenation was the dominant circulating metabolite after the intragastric administration of isochlorogenic acid A. The results obtained will be useful for further study of elucidating potential bioactive metabolites which can provide better explanation of the pharmacological and/or toxicological effects of this compound.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HPLC/Q-TOF MS; gut microbiota; isochlorogenic acid A; metabolite identification; rats

Mesh:

Substances:

Year:  2017        PMID: 28052484     DOI: 10.1002/bmc.3927

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

1.  Isochlorogenic Acid A Attenuates the Progression of Liver Fibrosis Through Regulating HMGB1/TLR4/NF-κB Signaling Pathway.

Authors:  Xin Liu; Kai Huang; Ru Jiao Zhang; Dan Mei; Bo Zhang
Journal:  Front Pharmacol       Date:  2020-05-01       Impact factor: 5.810

2.  An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation In Vitro Using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1,1-Diphenyl-2-picrylhydrazyl-Based Assay.

Authors:  Xiaoming Wang; Xiaoyan Chang; Xiaomei Luo; Meifeng Su; Rong Xu; Jun Chen; Yi Ding; Yue Shi
Journal:  Front Pharmacol       Date:  2019-07-25       Impact factor: 5.810

3.  Identification of the metabolites of isochlorogenic acid A in rats by UHPLC-Q-Exactive Orbitrap MS.

Authors:  Kaiyan Gong; Yuan Yang; Kailin Li; Lian Zhu; Xinjun Zhi; Wei Cai
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.